| The management of superficial bladder cancer: an interactive seminar. | |
| | |
MedLine Citation:
|
PMID: 8881945 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: To determine the current management of superficial bladder cancer in the United Kingdom. METHODS: An interactive seminar with a series of questions about management and hypothetical clinical scenarios was conducted at the 1995 conference of the British Association of Urological Surgeons. The responses of the audience were recorded electronically and analysed. RESULTS: The results showed that there is a wide variation in practice and some confusion over the place of intravesical treatment using cytotoxic drugs and bacille Calmette-Guérin. CONCLUSIONS: The management of superficial bladder cancer could be improved by a more widespread use of intravesical therapy, along with the introduction of local protocols and national guidelines. |
| | |
Authors:
|
J P McFarlane; B W Ellis; S J Harland |
Related Documents
:
|
20205975 - Identification and treatment of protein-energy malnutrition in renal disease. 10724575 - Auditing the implementation of sign (scottish intercollegiate guidelines network) clini... 15311575 - Effective management of home exacerbations (yellow zone) of asthma. 18257045 - Effect of a cd-rom-based educational intervention on resident knowledge and adherence t... 20203095 - Continuing professional development is associated with increasing physical therapists' ... 11464415 - The initial management of acute burns. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: British journal of urology Volume: 78 ISSN: 0007-1331 ISO Abbreviation: Br J Urol Publication Date: 1996 Sep |
Date Detail:
|
Created Date: 1996-12-17 Completed Date: 1996-12-17 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 15740090R Medline TA: Br J Urol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 372-8 Citation Subset: IM |
Affiliation:
|
Institute of Urology and Nephrology, St Peter's Hospital, London, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Intravesical Antineoplastic Agents / therapeutic use* BCG Vaccine / therapeutic use* Biopsy Chemotherapy, Adjuvant Hematuria / therapy Humans Urinary Bladder Neoplasms / therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents; 0/BCG Vaccine |
| Comments/Corrections | |
Comment In:
|
Br J Urol. 1997 May;79(5):818
[PMID:
9158535
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Quality of life in patients undergoing bacille Calmette-Guérin therapy for superficial bladder canc...
Next Document: The safety of finasteride used in benign prostatic hypertrophy: a non-interventional observational c...